Literature DB >> 24130046

Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.

Jonathan M Davis1, Stevan G Severtson, Becki Bucher-Bartelson, Richard C Dart.   

Abstract

BACKGROUND: Prescription drug abuse is a critical problem in the USA and has been linked to more deaths than automobile accidents. Despite this growing epidemic, the USA lacks a timely early warning system. Poison centers (PCs) have the potential to act as sentinel reporting entities for prescription drug abuse and misuse due to near-real-time data reporting and abundant coverage in the USA.
METHODS: Data from the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System PC program were compared with data from the Drug Abuse Warning Network (DAWN) from 2004 through 2010. Population rates of PC call mentions regarding abuse and misuse of prescription opioids were compared with population rates of emergency department visit mentions of the same using linear regression. Products included in the analysis were the following: buprenorphine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, and oxycodone.
RESULTS: The strength of association between RADARS System PC data and DAWN emergency department visits regarding all opioids in aggregate was strong (R² = 0.81, p < 0.001). The correlations between the two programs at the drug class level also were strong for buprenorphine, hydrocodone, hydromorphone, methadone, and oxycodone (all R² > 0.70, all p < 0.01), significant for fentanyl (p = 0.05), and moderate for morphine (p = 0.09).
CONCLUSIONS: Data on prescription opioid drug abuse from the RADARS System PC program correlates well with emergency room data from DAWN. Due to timeliness of data, geographic coverage and strong associations with other warning systems, PC data can be used for sentinel reporting on prescription drug abuse and misuse in the USA.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  emergency department visits; pharmacoepidemiology; poison center calls; prescription drug abuse

Mesh:

Substances:

Year:  2013        PMID: 24130046     DOI: 10.1002/pds.3533

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016.

Authors:  Janetta L Iwanicki; S Geoff Severtson; Zachary Margolin; Nabarun Dasgupta; Jody L Green; Richard C Dart
Journal:  Am J Public Health       Date:  2018-12       Impact factor: 9.308

Review 2.  Current State of Opioid Therapy and Abuse.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

3.  A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text.

Authors:  Celeste A Mallama; James P Trinidad; Richard S Swain; Yueqin Zhao; Corinne Woods; Jana K McAninch
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-08-11       Impact factor: 2.890

4.  Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users.

Authors:  João Mauricio Castaldelli-Maia; Laura H Andrade; Katherine M Keyes; Magdalena Cerdá; Daniel J Pilowsky; Silvia S Martins
Journal:  J Psychiatr Res       Date:  2016-05-24       Impact factor: 4.791

5.  Public Health Effects of Medical Marijuana Legalization in Colorado.

Authors:  Jonathan M Davis; Bruce Mendelson; Jay J Berkes; Katie Suleta; Karen F Corsi; Robert E Booth
Journal:  Am J Prev Med       Date:  2015-09-16       Impact factor: 5.043

6.  The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.

Authors:  Di Liang; Yuyan Shi
Journal:  Drug Alcohol Depend       Date:  2019-11-21       Impact factor: 4.492

7.  The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.

Authors:  Yuyan Shi; Di Liang
Journal:  Addiction       Date:  2020-03-10       Impact factor: 6.526

8.  Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States.

Authors:  Janetta L Iwanicki; S Geoff Severtson; Heather McDaniel; Andrew Rosenblum; Chunki Fong; Theodore J Cicero; Matthew S Ellis; Steven P Kurtz; Mance E Buttram; Richard C Dart
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

9.  Opioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis.

Authors:  Marit F Hooijman; Adrian Martinez-De la Torre; Stefan Weiler; Andrea M Burden
Journal:  Lancet Reg Health Eur       Date:  2022-06-27

10.  Diversion and Illicit Sale of Extended Release Tapentadol in the United States.

Authors:  Richard C Dart; Hilary L Surratt; Marie-Claire Le Lait; Yami Stivers; Vikhyat S Bebarta; Clark C Freifeld; John S Brownstein; John J Burke; Steven P Kurtz; Nabarun Dasgupta
Journal:  Pain Med       Date:  2015-12-14       Impact factor: 3.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.